Main > ONCOLOGY (**) > Leukemia>Lymphocytic>Chronic *** > Treatment > IL. T. Brand Bendamustine***

---

IL. T. Brand Bendamustine***'s subsections
(*) EU Approval Date: ?
(*) JP>Approval Date: 2016. 08.26
(*) JP>Licensee
(*) USA Approval Date: 2013. 09.13
Company
Company/Licensee (JP)
Company/SubLicensee (JP)
Mechanism: Alkylating Agent
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2016. 09.27
TradeMark (EU)
TradeMark (JP)
TradeMark (JP) Web-Site
TradeMark (USA)
TradeMark (USA) Web-Site

IL. T. Brand Bendamustine***'s products
This section has no products